These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35276996)

  • 1. Development of a Novel Nutrition-Related Multivariate Biomarker for Mild Cognitive Impairment Based on the Plasma Free Amino Acid Profile.
    Ikeuchi T; Yano Y; Sato W; Morikawa F; Toru S; Nishimura C; Miyazawa N; Kuroha Y; Koike R; Tanaka S; Utsumi K; Kasuga K; Tokutake T; Ono K; Yano S; Naruse S; Yajima R; Hamano T; Yokoyama Y; Kitamura A; Kaneko E; Yamakado M; Nagao K
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35276996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment.
    Ikeuchi T; Kanda M; Kitamura H; Morikawa F; Toru S; Nishimura C; Kasuga K; Tokutake T; Takahashi T; Kuroha Y; Miyazawa N; Tanaka S; Utsumi K; Ono K; Yano S; Hamano T; Naruse S; Yajima R; Kawashima N; Kaneko C; Tachibana H; Yano Y; Kato Y; Toue S; Jinzu H; Kitamura A; Yokoyama Y; Kaneko E; Yamakado M; Nagao K
    Front Nutr; 2022; 9():1040476. PubMed ID: 36590218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.
    Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE
    J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
    Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
    J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians.
    Yang Z; Wen W; Jiang J; Crawford JD; Reppermund S; Levitan C; Slavin MJ; Kochan NA; Richmond RL; Brodaty H; Trollor JN; Sachdev PS
    Curr Alzheimer Res; 2016; 13(3):256-67. PubMed ID: 26679854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment.
    Marshall GA; Zoller AS; Kelly KE; Amariglio RE; Locascio JJ; Johnson KA; Sperling RA; Rentz DM; For The Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2014; 11(9):853-61. PubMed ID: 25274110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
    Liu Y; Li N; Zhou L; Li Q; Li W
    Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Poor Nutritional Status to Mild Cognitive Impairment in Patients with Coronary Artery Disease.
    Ishihara K; Izawa KP; Kitamura M; Ogawa M; Shimogai T; Kanejima Y; Morisawa T; Shimizu I
    J Nutr Health Aging; 2020; 24(10):1080-1086. PubMed ID: 33244564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between vitamin A, vitamin E and apolipoprotein E status with mild cognitive impairment among elderly people in low-cost residential areas.
    Shahar S; Lee LK; Rajab N; Lim CL; Harun NA; Noh MF; Mian-Then S; Jamal R
    Nutr Neurosci; 2013 Jan; 16(1):6-12. PubMed ID: 23321337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility].
    Hashidate H; Harada K; Asakawa Y; Yamagami T; Nihei K; Kaneya S; Yoshii C
    Nihon Koshu Eisei Zasshi; 2012 Aug; 59(8):532-43. PubMed ID: 23066632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project.
    Doorduijn AS; Visser M; van de Rest O; Kester MI; de Leeuw FA; Boesveldt S; Fieldhouse JLP; van den Heuvel EGHM; Teunissen CE; Scheltens P; van der Flier WM; de van der Schueren MAE
    Nutrients; 2019 May; 11(5):. PubMed ID: 31126170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong Relationship between Malnutrition and Cognitive Frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2).
    Chye L; Wei K; Nyunt MSZ; Gao Q; Wee SL; Ng TP
    J Prev Alzheimers Dis; 2018; 5(2):142-148. PubMed ID: 29616708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of CSF Neurogranin and
    Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
    Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
    Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
    Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Mild Cognitive Impairment, Dementia and Mortality: The Sydney Memory and Ageing Study.
    Lipnicki DM; Crawford J; Kochan NA; Trollor JN; Draper B; Reppermund S; Maston K; Mather KA; Brodaty H; Sachdev PS;
    J Am Med Dir Assoc; 2017 May; 18(5):388-395. PubMed ID: 28043804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.